| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |